GJO & Partners
← All funds

OneBio

Public data, unclaimed profile

Investisseur référencé à partir d'opérations publiées. Secteurs, pays, instruments et tickets affichés d'après ses opérations ; le fonds peut revendiquer sa fiche pour préciser sa thèse.

At a glance

Based on observed investment behaviour: 1 recorded deal

Investor type
Private equity or venture capital fund (inferred, not verified)
Capital type
Private equity (inferred from profile)
Observed ticket
1.6 M$, median 1.6 M$ (1 disclosed amount)
Countries
South Africa (1)
Activities
Pharmaceutical manufacturing (1)
Instruments
Equity (1)
Stages
Pre-Seed (1)
Recent activity
0 deal in 12 months, latest Jul 2025

Stated thesis versus observed behaviour

Fewer than three recorded deals: insufficient evidence to compare thesis and behaviour.

Does this fund fit your project?

Describe your need: the target list shows, for each source of capital, why it fits and which deals prove it.

Find my matches

Investment thesis

Criteria inferred from recorded deals: the fund has not stated its thesis yet.

Investment ticket
1.6 M$*
Instruments
Equity*
Preferred sectors
Healthcare*
Target geographies
South Africa*

* added from its deals

Stages (stated by the fund and from its deals)
Pre-Seed

Reference deals

Recent public deals: they say better than a thesis what the fund actually signs.

Altera Biosciences

July 2025 · South Africa
Pre-Seed1.6 M$EquityHealthcareLead

Activity : Pharmaceutical manufacturing

Altera Biosciences Bags $1.6M to Build ‘Off-the-Shelf’ Cells in Africa’s First Gene Therapy Play.

Co-investors E Squared

Source : launchbaseafrica.com

In short

OneBio invests tickets ranging from 1.6 M$ to 1.6 M$, across the following sectors: Healthcare, in the following areas: South Africa. Check in 30 seconds whether your company fits these criteria.